Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunization withStaphylococcus aureusiron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 8, Issue 3, Pages 336-346
Publisher
Informa UK Limited
Online
2012-04-06
DOI
10.4161/hv.18946
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Staphylococcus aureusphenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection
- (2011) Lorena Tuchscherr et al. EMBO Molecular Medicine
- A new view on development of aStaphylococcus aureusvaccine
- (2011) Brad Spellberg et al. Human vaccines & immunotherapeutics
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis
- (2010) Cheng-Chi Chao et al. AUTOIMMUNITY
- Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia
- (2010) N. J. Verkaik et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Staphylococcus aureuscapsule type 8 antibodies provide inconsistent efficacy in murine Models of staphylococcal infection
- (2010) James Cook et al. Human vaccines & immunotherapeutics
- Proinflammatory Cytokine Gene Expression in the Stomach Correlates with Vaccine-Induced Protection againstHelicobacter pyloriInfection in Mice: an Important Role for Interleukin-17 during the Effector Phase
- (2010) Carl-Fredrik Flach et al. INFECTION AND IMMUNITY
- Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice
- (2010) David Skurnik et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice
- (2010) John S. Cho et al. JOURNAL OF CLINICAL INVESTIGATION
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
- (2010) Anne Puel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development
- (2010) Richard Malley JOURNAL OF MOLECULAR MEDICINE-JMM
- IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge
- (2010) Hwan Keun Kim et al. VACCINE
- Targeted Immunotherapy for Staphylococcal Infections
- (2009) Michael Otto BIODRUGS
- The rise and rise ofStaphylococcus aureus: laughing in the face of granulocytes
- (2009) S. Anwar et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Translational Mini-Review Series on Th17 Cells: Function and regulation of human T helper 17 cells in health and disease
- (2009) S. Q. Crome et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Selection and Characterization of Murine Monoclonal Antibodies to Staphylococcus aureus Iron-Regulated Surface Determinant B with Functional Activity In Vitro and In Vivo
- (2009) M. Brown et al. Clinical and Vaccine Immunology
- Immunogenicity of Toxins duringStaphylococcus aureusInfection
- (2009) Nelianne J. Verkaik et al. CLINICAL INFECTIOUS DISEASES
- Induction of antibodies by Staphylococcus aureus nasal colonization in young children
- (2009) N.J. Verkaik et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunological surrogate marker of rAls3p-N vaccine-induced protection againstStaphylococcus aureus: Table 1
- (2009) Lin Lin et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Interleukin-17 Is Required for T Helper 1 Cell Immunity and Host Resistance to the Intracellular Pathogen Francisella tularensis
- (2009) Yinyao Lin et al. IMMUNITY
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- The roles of IL-17A in inflammatory immune responses and host defense against pathogens
- (2009) Yoichiro Iwakura et al. IMMUNOLOGICAL REVIEWS
- Precarious Balance: Th17 Cells in Host Defense
- (2009) A. Peck et al. INFECTION AND IMMUNITY
- Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome
- (2009) Yoshiyuki Minegishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice
- (2009) Lin Lin et al. PLoS Pathogens
- Staphylococcus aureusantigens and challenges in vaccine development
- (2008) John R Middleton Expert Review of Vaccines
- Human immunodeficiency: Connecting STAT3, Th17 and human mucosal immunity
- (2008) Alain Fischer IMMUNOLOGY AND CELL BIOLOGY
- The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus
- (2008) B. Spellberg et al. INFECTION AND IMMUNITY
- Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency
- (2008) Y. Minegishi et al. INTERNATIONAL IMMUNOLOGY
- Vaccination and passive immunisation against Staphylococcus aureus
- (2008) Adam C. Schaffer et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Deficiency of Th17 cells in hyper IgE syndrome due to mutations inSTAT3
- (2008) Cindy S. Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neutrophil Depletion Causes a Fatal Defect in Murine Pulmonary Staphylococcus aureus clearance
- (2008) Charles M. Robertson et al. JOURNAL OF SURGICAL RESEARCH
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
- (2008) Joshua D. Milner et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started